Description

Global and national initiatives have worked concurrently to support and sustain local pharmaceutical production (LPP) to ensure access to quality essential medicines. Categorisation of the LPP is a key catalyst for growth of the sector in terms of product range, security of the medicines, access and availability of quality essential medicines. A stimulus scheme to support and sustain LPP must adhere to conformance to international standards of products, processes, facilities and regulatory function, in a manner that guarantees the value chain. The scheme must also be a foundation for innovation, research and development, human resource development and attract investment in the sector. The scheme should inform the levels of quality performance and risk categorisation.